hrcak mascot   Srce   HID

Acta clinica Croatica, Vol. 57 No. 2, 2018.

Izvorni znanstveni članak
https://doi.org/10.20471/acc.2018.57.02.09

ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores

Tonći Božin ; Department of Gastroenterology, Hepatology and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia;
Sanda Mustapić ; Department of Gastroenterology, Hepatology and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia;
Tomislav Bokun ; Department of Gastroenterology, Hepatology and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia;
Leonardo Patrlj ; Department of Abdominal Surgery, Dubrava University Hospital, Zagreb, Croatia; University of Zagreb, School of Medicine, Zagreb, Croatia;
Mislav Rakić ; Department of Abdominal Surgery, Dubrava University Hospital, Zagreb, Croatia;
Gorana Aralica ; University of Zagreb, School of Medicine, Zagreb, Croatia; Department of Pathology, Dubrava University Hospital, Zagreb, Croatia;
Milan Kujundžić ; Department of Gastroenterology, Hepatology and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia; University of Zagreb, School of Medicine, Zagreb, Croatia;
Vladimir Trkulja ; Department of Pharmacology, University of Zagreb, School of Medicine, Zagreb, Croatia
Ivica Grgurević   ORCID icon orcid.org/0000-0003-0520-3483 ; Department of Gastroenterology, Hepatology and Clinical Nutrition, Dubrava University Hospital, Zagreb, Croatia;University of Zagreb, School of Medicine, Zagreb, Croatia;

Puni tekst: engleski, pdf (751 KB) str. 292-300 preuzimanja: 41* citiraj
APA 6th Edition
Božin, T., Mustapić, S., Bokun, T., Patrlj, L., Rakić, M., Aralica, G., ... Grgurević, I. (2018). ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores. Acta clinica Croatica, 57 (2), 292-300. https://doi.org/10.20471/acc.2018.57.02.09
MLA 8th Edition
Božin, Tonći, et al. "ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores." Acta clinica Croatica, vol. 57, br. 2, 2018, str. 292-300. https://doi.org/10.20471/acc.2018.57.02.09. Citirano 22.02.2019.
Chicago 17th Edition
Božin, Tonći, Sanda Mustapić, Tomislav Bokun, Leonardo Patrlj, Mislav Rakić, Gorana Aralica, Milan Kujundžić, Vladimir Trkulja i Ivica Grgurević. "ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores." Acta clinica Croatica 57, br. 2 (2018): 292-300. https://doi.org/10.20471/acc.2018.57.02.09
Harvard
Božin, T., et al. (2018). 'ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores', Acta clinica Croatica, 57(2), str. 292-300. doi: https://doi.org/10.20471/acc.2018.57.02.09
Vancouver
Božin T, Mustapić S, Bokun T, Patrlj L, Rakić M, Aralica G i sur. ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores. Acta clinica Croatica [Internet]. 2018 [pristupljeno 22.02.2019.];57(2):292-300. doi: https://doi.org/10.20471/acc.2018.57.02.09
IEEE
T. Božin, et al., "ALBI Score as a Predictor of Survival in Patients with Compensated Cirrhosis Resected for Hepatocellular Carcinoma: Exploratory Evaluation in Relationship to PALBI and MELD Liver Function Scores", Acta clinica Croatica, vol.57, br. 2, str. 292-300, 2018. [Online]. doi: https://doi.org/10.20471/acc.2018.57.02.09

Sažetak
The aim of the study was to explore predictive value of the ALBI, PALBI and MELD scores on survival in patients resected for hepatocellular carcinoma with compensated liver cirrhosis and no macrovascular infi ltration. In this retrospective study, longitudinal survival analysis was performed. We analyzed patient/tumor characteristics and MELD, ALBI and PALBI scores as liver function tests for predicting survival outcome. Survival was analyzed from the date of liver resection until death, liver transplantation, or end of follow-up. Patients were stratifi ed for age, cirrhosis etiology, presence of esophageal varices, hepatocellular carcinoma stage, microvascular invasion, histologic diff erentiation, and resection margins. We identifi ed 38 patients (alcoholic cirrhosis in 84.2% of patients) resected over an 8-year period. Median preoperative MELD score was 8, ALBI score -2.63, and PALBI score -2.38. During the follow-up period, 24 patients died. Estimated median survival time was 36 months. Microvascular invasion was observed in 33 patients. Higher ALBI score was associated with 23.1% higher relative risk of death. PALBI score was associated with 12.1% higher relative risk of death, whereas MELD score was not associated with the risk of death. In conclusion, ALBI score demonstrated signifi cant predictive capabilities for survival in patients with compensated cirrhosis resected for hepatocellular carcinoma.

Ključne riječi
Carcinoma, Hepatocellular; Liver Function Tests; Hepatectomy; Liver Transplantation; Esophageal and Gastric Varices; Liver Cirrhosis, Alcoholic

Hrčak ID: 207543

URI
https://hrcak.srce.hr/207543

[hrvatski]

Posjeta: 99 *